Tomer Meirson

22PUBLICATIONS
61CO-AUTHORS
Probability theoryCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 01, 2026
Interpreting Treatment Effects Using Posterior Probabilities: A Bayesian Reanalysis of 230 Phase III Oncology Trials.

|Jul 09, 2025
How the addition of selinexor/bortezomib/dexamethasone as a Category 1 recommendation may erode outcomes.

Zena Chahine, Tomer Meirson, Shai Gilboa

|Jan 31, 2025
IRS2 as a driver of brain metastasis in colorectal cancer: A potential target for novel therapeutic strategies.

Inbal Greenberg, Fayhaa Khair-Dabour, Keren Merenbakh-Lamin

|Jan 27, 2025
Survival-Inferred Fragility of Statistical Significance in Phase III Oncology Trials.

Alexander D Sherry, Yufei Liu, Pavlos Msaouel

|Aug 12, 2024
Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial Misinterpretation.

Timothy A Lin, Zachary R McCaw, Alex Koong

|May 06, 2024
Peptriever: a Bi-Encoder approach for large-scale protein-peptide binding search.

Roni Gurvich, Gal Markel, Ziaurrehman Tanoli

Pageof 4

Frequent Collaborators

4 joint publications

Ethan B Ludmir

3 joint publications

Alex Koong

3 joint publications

Hava Gil-Henn

3 joint publications

Timothy A Lin